The future of NGS in gynecology looks promising. Advances in technology and bioinformatics will continue to improve the accuracy, speed, and cost-effectiveness of genetic sequencing. Integration of NGS with other omics technologies, such as proteomics and metabolomics, will offer a more comprehensive understanding of gynecological diseases. Personalized medicine, driven by NGS, will likely become the standard of care, leading to more effective and tailored treatment strategies for patients.
